Estimation of the herd protection of Haemophilus influenzae type b conjugate vaccine against radiologically confirmed pneumonia in children under 2 years old in Dhaka, Bangladesh

Vaccine

Volumn 32, Issue 8, 2014, Pages 944-948

  Chen, Wei Ju ^a   Moulton, Lawrence H ^a   Saha, Samir K ^b   Mahmud, Abdullah Al ^c   Arifeen, Shams El ^c   Baqui, Abdullah H ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b DHAKA SHISHU HOSPITAL   (Bangladesh)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

Haemophilus influenzae type b (Hib) vaccine; Herd protection; Vaccine coverage

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

AGE; ARTICLE; BANGLADESH; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DEVELOPING COUNTRY; FEMALE; HUMAN; INFANT; INFLUENZA VACCINATION; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEIGHBORHOOD; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

HAEMOPHILUS INFLUENZAE TYPE B (HIB) VACCINE; HERD PROTECTION; VACCINE COVERAGE;

BACTERIAL CAPSULES; BANGLADESH; CASE-CONTROL STUDIES; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNITY, HERD; INFANT; MALE; PNEUMONIA, BACTERIAL; VACCINATION; VACCINES, CONJUGATE;

EID: 84892970138     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.12.052     Document Type: Article

References (26)

1. WHO WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec 2006, 81:445-452.
2. Booy R., Hodgson S., Carpenter L., Mayon-White R.T., Slack M.P., Macfarlane J.A., et al. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet 1994, 344:362-366.
3. Eskola J., Kayhty H., Takala A.K., Peltola H., Ronnberg P.R., Kela E., et al. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med 1990, 323:1381-1387.
4. Santosham M., Wolff M., Reid R., Hohenboken M., Bateman M., Goepp J., et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med 1991, 324:1767-1772.
5. Mulholland K., Hilton S., Adegbola R., Usen S., Oparaugo A., Omosigho C., et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997, 349:1191-1197.
6. Baqui A.H., El Arifeen S., Saha S.K., Persson L., Zaman K., Gessner B.D., et al. Effectiveness of Haemophilus influenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study. Pediatr Infect Dis J 2007, 26:565-571.
7. Levine O.S., Lagos R., Munoz A., Villaroel J., Alvarez A.M., Abrego P., et al. Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. Pediatr Infect Dis J 1999, 18:1060-1064.
8. de Andrade A.L., de Andrade J.G., Martelli C.M., e Silva S.A., de Oliveira R.M., Costa M.S., et al. Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a case-control study in Brazil. Int J Epidemiol 2004, 33:173-181.
9. WHO Pneumonia Vaccine Trial Investigators' Group Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children 2001.
10. Halloran M.E., Haber M., Longini I.M., Struchiner C.J. Direct and indirect effects in vaccine efficacy and effectiveness. Am J Epidemiol 1991, 133:323-331.
11. Rushdy A., Ramsay M., Heath P.T., Azzopardi H.J., Slack M.P. Infant Hib vaccination and herd immunity. J Pediatr 1999, 134:253-254.
12. Adegbola R.A., Secka O., Lahai G., Lloyd-Evans N., Njie A., Usen S., et al. Elimination of Haemophilus influenzae type b (Hib) disease from the Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 2005, 366:144-150.
13. Moulton L.H., Chung S., Croll J., Reid R., Weatherholtz R.C., Santosham M. Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population. Int J Epidemiol 2000, 29:753-756.
14. Cherian T., Mulholland E.K., Carlin J.B., Ostensen H., Amin R., de Campo M., et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ 2005, 83:353-359.
15. Wacholder S., Silverman D.T., McLaughlin J.K., Mandel J.S. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol 1992, 135:1029-1041.
16. Lemeshow S., Robinson D. Surveys to measure programme coverage and impact: a review of the methodology used by the expanded programme on immunization. World Health Stat Q 1985, 38:65-75.
17. Bulkow L.R., Wainwright R.B., Letson G.W., Chang S.J., Ward J.I. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants. Pediatr Infect Dis J 1993, 12:484-492.
18. Vyas S., Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan 2006, 21:459-468.
19. Dupont W.D. Power calculations for matched case-control studies. Biometrics 1988, 44:1157-1168.
20. Verghese V.P., Friberg I.K., Cherian T., Raghupathy P., Balaji V., Lalitha M.K., et al. Community effect of Haemophilus influenzae type b vaccination in India. Pediatr Infect Dis J 2009, 28:738-740.
21. Diez-Domingo J., Pereiro I., Morant A., Gimeno C., San-Martin M., Gonzalez A. Impact of non-routine vaccination on the incidence of invasive Haemophilus influenzae type b (Hib) disease: experience in the autonomous region of Valencia, Spain. J Infect 2001, 42:257-260.
22. Ali M., Emch M., von Seidlein L., Yunus M., Sack D.A., Rao M., et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 2005, 366:44-49.
23. Emch M., Ali M., Park J.K., Yunus M., Sack D.A., Clemens J.D. Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunity. Int J Epidemiol 2006, 35:1044-1050.
24. Kim D.R., Ali M., Sur D., Khatib A., Wierzba T.F. Determining optimal neighborhood size for ecological studies using leave-one-out cross validation. Int J Health Geogr 2012, 11:10.
25. Najnin N., Bennett C.M., Luby S.P. Inequalities in care-seeking for febrile illness of under-five children in urban Dhaka, Bangladesh. J Health Popul Nutr 2011, 29:523-531.
26. El Arifeen S., Baqui A.H., Victora C.G., Black R.E., Bryce J., Hoque D.M., et al. Sex and socioeconomic differentials in child health in rural Bangladesh: findings from a baseline survey for evaluating integrated management of childhood illness. J Health Popul Nutr 2008, 26:22-35.